Ka-Vit Tropfen (Phytomenadione)

Phytomenadione serves as a cofactor for the gamma‑carboxylation of specific clotting factors (II, VII, IX, X) in the liver. This biochemical step enables the factors to bind calcium, which is essential for the formation of a stable fibrin clot and normal hemostasis.

The dose of Ka‑Vit Tropfen is individualized and determined by a qualified prescriber based on the patient’s age, clinical condition, and laboratory results. Healthcare professionals calculate the appropriate amount and frequency to achieve the desired therapeutic effect.

Safety data for phytomenadione in pregnancy and lactation are limited. It should only be used when the potential benefit to the mother or infant outweighs any possible risk, and the decision should be made by a healthcare provider.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Ka‑Vit Tropfen is an oral liquid formulation of phytomenadione, whereas many alternatives are available as injectable phytonadione or synthetic vitamin K analogues. Oral drops offer ease of administration, especially for infants and patients with needle aversion, but may have slower onset compared with parenteral preparations.

Store Ka‑Vit Tropfen at ambient temperature, preferably below 25 °C. Keep the bottle tightly closed in its original packaging, protect it from moisture and direct sunlight, and avoid freezing. Check the label for any specific expiry information before use.

Ka‑Vit Tropfen is administered orally using the calibrated dropper provided with the product. The prescribed number of drops is measured directly into the mouth or mixed with a small amount of food or liquid, as directed by the prescribing clinician.

Serious adverse reactions, although rare, include anaphylaxis, severe hypersensitivity, hemolysis, thrombosis, and significant liver enzyme elevations. Patients should be monitored for signs of allergic reaction, unexpected clot formation, or abnormal bleeding and seek immediate medical attention if these occur.

Ka‑Vit Tropfen should be avoided in individuals with known hypersensitivity to phytomenadione or any excipients in the formulation. It is also contraindicated in patients with documented severe vitamin K toxicity or those for whom vitamin K supplementation is medically inappropriate, as determined by a healthcare professional.